Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lefty will be left out.
That's awesome timing. Go ENZC
Get ready for all kinds of crazy comments because we're moving up and some crazy things are going to be said. Don't be influenced. Know your DD know what you own. ENZC $
It will happen Dusty. Just hold on and hang in there. This is not your every day pinky. These are cures for HIV and Covid19 that we are investing in. Sky is the limit IMHO.
Thanks for those encouraging words Brez; up up and away. I appreciate all the input you are contributing to this board.
I'm up $29,000 today so far today somebody pinched me I can't believe it! After dozens of losses down here in the basement I finally have a winner.
With all the hype about the news coming I have a question ~ is the price already baked in? And another question ~when the news does come does that mean buy on the rumor selling the news type of situation?
.08 on ETRADE
Tomorrow Manny will be getting their tickets for Tuesday's fireworks
Tuesday December 1st
But Bud, this is not a company selling MLB ice cream or gummies like Ver~s. This is a company with cures.
I read some time ago a statement by Charles and I wish I could find that statement I can't find it for the Love of money but he said he is for a partnership but he is adamantly opposed to a buyout.
Awesome.
Anyone know how many shareholders of record there are?
"Are we at $150.00 per share yet ?"
I am confident that one day it will be there or exceed $150. Enzc is ushering in a brand new era of medicine, curing viral infections and treating others without side effects. The entire planet will benefit from the results of this research.
A yes Moose's and I believe it'll be in the not too distant future.
From copper to silver today in this abbreviated session. Holding for paper. I must admit that with an $11,000 gain today I was tempted to sell.
It's FOMO time. Looking for a nice close.
My shoulder hurts. Get this bag off me please. Thank you Lord.
Bar charts.com is a resistance of 05 does anyone else have a different resistance number? It seems like 04 is more like it.
Welcome back Bonnie Mac.
~Lock your shares. Set your sell orders high. Don't let the shorts borrow your shares.
~God bless this life saving company. History is in the making for a new era in medicine.
Thanks shell Man for figuring that out.
Anyone have any DD on IMMB. OTC shows Harry as President.
ECPO is no longer listed on OTC.
I believe they were acquired in 2017~
Eco Petroleum-ECPO Completes Acquisition of Immunotherapy Drug Development Company
MONROVIA, CA--(Marketwired - Jun 14, 2017) - Eco Petroleum Solutions, Inc. (OTC PINK: ECPO) announces that it has completed the acquisition of Immunotech Laboratories, Inc. (OTC PINK: IMMB), a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases, in a share exchange transaction. Immunotech is committed to creating drugs for the better health of mankind and the realization of shareholder value for the existing shareholder groups of
the two entities.
Immunotech's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.
The US Patented ITV-1 treatment has successfully completed Phase I, II and III clinical testing in Sophia, Bulgaria through Immunotech Laboratories BG - Europe LTD, a subsidiary of the acquired entity. The Phase III testing was conducted at the National Center of Infectious and Parasitic Diseases in Sophia, Bulgaria (www.ncipd.org) on a test group of salvage patients suffering from HIV/AIDS using the best modern methods as approved at the latest World Practice Conference. The final report issued by the Ministry of Health demonstrated improvement in the immune indices in the absolute number of Ly, CD3 T, CD4 T, CD8 T, B Ly, NK and in the percentage of CD3 T, CD4 T, CD8 T, B Ly, NK and of the index CD4/CD8, decrease in the viral load, a good treatment effect on opportunistic infections, compatibility with all of the other modern antiretroviral drugs, and exceptional tolerance in all patients with a complete lack of any major side effects. Approximately eighty percent of the test subjects reported viral loads at a nil level as a result of the treatment. The final report of the clinical trial is available on our website: www.immunotechlab.com
This is from the OTC markets website~
Early closings, at 2PM, are observed for the day after Thanksgiving, the day before Independence Day and Christmas Eve if they do not occur on a weekend.
It is a partnership, however ENZC owns 49% of common shares.
The following is from a Feb. 6th PR~
Enzolytics continues to work with its Bulgarian partner, Immunotech Laboratories, BG, to complete the validation of the production process to submit the final documents to the Bulgarian drug agency in order to obtain registration.
I have 650,000 & plan on selling 50,000 @.10 then ride free.
Enzolytics currently holds a 49% Interest in Immunotech Laboratories BG-Europe. Immunotech BG-Europe has a license for the development and commercialization of Enzolytics Patented ITV-1 Technology. Immunotech BG-Europe , under the branded ImmunH , utilizing the technology has successfully completed Phase III clinical trials at the Specialized Hospital for Active Treatment of Infectious and Parasite Disease in Sofia, Bulgaria, specific for the treatment of HIV/AIDS.
ImmunoTech Laboratories BG-Europe has filed for a mass use permit, Phase IV, in Bulgaria. Enzolytics is seeking a Contract Manufacturing Organization (CMO) in the United States to produce the Immunotherapy Treatment to be used as the validation batch in coordination with the Bulgarian regulatory authority and Immunotech BG-Europe.
Additionally, ImmunoTech BG-Europe has informed Enzolytics that they will be seeking to register the ImmunH product as a ImmuneModulator, allowing use as an adjunct in additional applications to regulate or normalize the Immune System.
www.ImmunH.com
Enzolytics owns 49% of Immunotech Laboratories BG-Europe. So,if you are invested in this stock you benefit from three entities. Wow.
OTC has been known to be slow taking down stop signs.
Given the probability of very frequent and dynamic catalysts in the days and weeks ahead, I see only modest retraces over a several weeks run. ~~ex. Completed filings very soon/lab testing/funding, etc.
I agree veloyt. I tried it once on this stock. Lost a few shares in the process. Holding strong and adding little by little. See you at $$.
Right Godfather. This is a deal you can't refuse if you understand that this is history in the making.
Totally
FOMO's arriving.
Very normal retrace no problems here /actually a great time to buy more like I just did.GLTA
.0393 on ETRADE my account.
.041 premarket guys and gals